The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis

被引:6
|
作者
Marzec, Jacek [1 ]
Ross-Adams, Helen [1 ]
Pirro, Stefano [1 ]
Wang, Jun [1 ]
Zhu, Yanan [2 ]
Mao, Xueying [2 ]
Gadaleta, Emanuela [1 ]
Ahmad, Amar S. [3 ]
North, Bernard V. [3 ]
Kammerer-Jacquet, Solene-Florence [2 ]
Stankiewicz, Elzbieta [2 ]
Kudahetti, Sakunthala C. [2 ]
Beltran, Luis [4 ]
Ren, Guoping [5 ]
Berney, Daniel M. [2 ,4 ]
Lu, Yong-Jie [2 ]
Chelala, Claude [1 ,6 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, Bioinformat Unit, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[2] Queen Mary Univ London, Barts Canc Inst, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[3] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med, Ctr Canc Prevent, London EC1M 6BQ, England
[4] Barts Hlth NHS, Dept Pathol, London E1 F1R, England
[5] Zhejiang Univ, Med Coll, Dept Pathol, Affiliated Hosp 1, Hangzhou 310058, Peoples R China
[6] Queen Mary Univ London, Life Sci Initiat, Ctr Computat Biol, London EC1M 6BQ, England
基金
英国工程与自然科学研究理事会;
关键词
prostate cancer; tumorigenesis; mRNA; RNAseq; transcriptomic; data integration;
D O I
10.3390/cancers13020345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary There is a tremendous amount of gene expression information available for prostate cancer, but very few tools exist to combine the disparate datasets generated across sample types and technical platforms. We present a method of integrating different types of expression data from different study cohorts to increase analytic power, and improve our understanding of the molecular changes underlying the development and progression of prostate cancer from normal to advanced disease. Using this approach, we identified nine additional disease stage-specific candidate genes with prognostic significance, which were not identified in any one study alone. We have developed a free online tool summarizing our results, and making the complete combined dataset available for further translational research. Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microarray-based data still constitute the majority of available information on other clinically valuable samples, including archive material. Using prostate cancer (PC) as a model, we developed a robust analytical framework to integrate data across different technical platforms and disease subtypes to connect distinct disease stages and reveal potentially relevant genes not identifiable from single studies alone. We reconstructed the molecular profile of PC to yield the first comprehensive insight into its development, by tracking changes in mRNA levels from normal prostate to high-grade prostatic intraepithelial neoplasia, and metastatic disease. A total of nine previously unreported stage-specific candidate genes with prognostic significance were also found. Here, we integrate gene expression data from disparate sample types, disease stages and technical platforms into one coherent whole, to give a global view of the expression changes associated with the development and progression of PC from normal tissue through to metastatic disease. Summary and individual data are available online at the Prostate Integrative Expression Database (PIXdb), a user-friendly interface designed for clinicians and laboratory researchers to facilitate translational research.
引用
收藏
页码:1 / 24
页数:25
相关论文
共 50 条
  • [31] The Metabolic Landscape of Prostate Cancer
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Loda, Massimo
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (01): : 28 - 36
  • [32] The Genomic Landscape of Prostate Cancer
    Spans, Lien
    Clinckemalie, Liesbeth
    Helsen, Christine
    Vanderschueren, Dirk
    Boonen, Steven
    Lerut, Evelyne
    Joniau, Steven
    Claessens, Frank
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06) : 10822 - 10851
  • [33] Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer
    Trecarten, Shaun
    Liss, Michael A.
    Hamilton-Reeves, Jill
    Digiovanni, John
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [34] Epigenetic reprogramming during prostate cancer progression: A perspective from development
    Goel, Sakshi
    Bhatia, Vipul
    Biswas, Tanay
    Ateeq, Bushra
    SEMINARS IN CANCER BIOLOGY, 2022, 83 : 136 - 151
  • [35] The androgen receptor gene and its influence on the development and progression of prostate cancer
    Montgomery, JS
    Price, DK
    Figg, WD
    JOURNAL OF PATHOLOGY, 2001, 195 (02) : 138 - 146
  • [36] Drug Insight: role of the androgen receptor in the development and progression of prostate cancer
    Taplin, Mary-Ellen
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (04): : 236 - 244
  • [37] Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
    Kukkonen, Konsta
    Taavitsainen, Sinja
    Huhtala, Laura
    Uusi-Makela, Joonas
    Granberg, Kirsi J.
    Nykter, Matti
    Urbanucci, Alfonso
    CANCERS, 2021, 13 (13)
  • [38] Crucial role of noncoding RNA in driving prostate cancer development and progression
    Guo, Haiyang
    Ahmed, Musaddeque
    Hua, Junjie
    Soares, Fraser
    He, Housheng Hansen
    EPIGENOMICS, 2017, 9 (01) : 1 - 3
  • [39] Renin-angiotensin system: role in the development and progression of prostate cancer
    Chernogubova, E. A.
    Kogan, M., I
    ONKOUROLOGIYA, 2020, 16 (04): : 181 - 190
  • [40] Lymphatic Dissemination in Prostate Cancer: Features of the Transcriptomic Profile and Prognostic Models
    Pudova, Elena A.
    Kobelyatskaya, Anastasiya A.
    Katunina, Irina V.
    Snezhkina, Anastasiya V.
    Fedorova, Maria S.
    Pavlov, Vladislav S.
    Bakhtogarimov, Ildar R.
    Lantsova, Margarita S.
    Kokin, Sergey P.
    Nyushko, Kirill M.
    Alekseev, Boris Ya.
    Kalinin, Dmitry V.
    Melnikova, Nataliya V.
    Dmitriev, Alexey A.
    Krasnov, George S.
    Kudryavtseva, Anna V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)